NO761926L - - Google Patents
Info
- Publication number
- NO761926L NO761926L NO761926A NO761926A NO761926L NO 761926 L NO761926 L NO 761926L NO 761926 A NO761926 A NO 761926A NO 761926 A NO761926 A NO 761926A NO 761926 L NO761926 L NO 761926L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- hydrogen
- quinoline
- alkyl
- aralkyl
- Prior art date
Links
- -1 amino, hydroxy Chemical group 0.000 claims description 46
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 13
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 125000003107 substituted aryl group Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical class C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 claims description 7
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 7
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 125000004954 trialkylamino group Chemical group 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims description 2
- 239000000908 ammonium hydroxide Substances 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 2
- 125000005270 trialkylamine group Chemical group 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Chemical group 0.000 claims 1
- 239000001099 ammonium carbonate Substances 0.000 claims 1
- 235000012501 ammonium carbonate Nutrition 0.000 claims 1
- 150000003841 chloride salts Chemical class 0.000 claims 1
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- LJDZFAPLPVPTBD-UHFFFAOYSA-N nitroformic acid Chemical compound OC(=O)[N+]([O-])=O LJDZFAPLPVPTBD-UHFFFAOYSA-N 0.000 claims 1
- 150000007530 organic bases Chemical class 0.000 claims 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000013078 crystal Substances 0.000 description 11
- 238000000921 elemental analysis Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000155 melt Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- HLNJFEXZDGURGZ-UHFFFAOYSA-M 1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1 HLNJFEXZDGURGZ-UHFFFAOYSA-M 0.000 description 2
- UJIRBIMPTSELQD-UHFFFAOYSA-N 8-methyl-4-oxo-1h-quinoline-3-carboxylic acid Chemical compound N1C=C(C(O)=O)C(=O)C2=C1C(C)=CC=C2 UJIRBIMPTSELQD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- NDCFBPDNHOZORS-UHFFFAOYSA-N 1,2-dihydroquinoline-3-carboxylic acid Chemical compound C1=CC=C2NCC(C(=O)O)=CC2=C1 NDCFBPDNHOZORS-UHFFFAOYSA-N 0.000 description 1
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical compound C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 description 1
- ZSEJADLCFCHIGX-UHFFFAOYSA-N 1-ethyl-4-oxoquinoline-3-carboxylic acid Chemical compound C1=CC=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 ZSEJADLCFCHIGX-UHFFFAOYSA-N 0.000 description 1
- YTWMJESCVWECIP-UHFFFAOYSA-N 1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid Chemical compound COC1=CC=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 YTWMJESCVWECIP-UHFFFAOYSA-N 0.000 description 1
- MNLSUJGUPANTQB-UHFFFAOYSA-N 1-ethyl-7-methyl-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(C)C=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MNLSUJGUPANTQB-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- RXXCIBALSKQCAE-UHFFFAOYSA-N 3-methylbutoxymethylbenzene Chemical compound CC(C)CCOCC1=CC=CC=C1 RXXCIBALSKQCAE-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- YVRGGPBWRTYCDP-UHFFFAOYSA-N 6-chloro-1-ethyl-4-oxoquinoline-3-carboxylic acid Chemical compound ClC1=CC=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 YVRGGPBWRTYCDP-UHFFFAOYSA-N 0.000 description 1
- HVEINHUJRQCZNZ-UHFFFAOYSA-N 6-nitro-4-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)C(C(=O)O)=CNC2=C1 HVEINHUJRQCZNZ-UHFFFAOYSA-N 0.000 description 1
- KSGSZGACXQALEU-UHFFFAOYSA-N 7-hydroxy-4-oxo-1h-quinoline-3-carboxylic acid Chemical compound OC1=CC=C2C(=O)C(C(=O)O)=CNC2=C1 KSGSZGACXQALEU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- SNHCYVGJJIKKNG-UHFFFAOYSA-N 8-oxo-5h-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid Chemical compound C1=C2C(=O)C(C(=O)O)=CNC2=CC2=C1OCO2 SNHCYVGJJIKKNG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005021 aminoalkenyl group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- ZXIJMRYMVAMXQP-UHFFFAOYSA-N cycloheptene Chemical compound C1CCC=CCC1 ZXIJMRYMVAMXQP-UHFFFAOYSA-N 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- PYPCDUKQEIPHAF-UHFFFAOYSA-N diethyl 2-(anilinomethylidene)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)=CNC1=CC=CC=C1 PYPCDUKQEIPHAF-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-O isoquinolin-2-ium Chemical compound C1=[NH+]C=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-O 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Description
Fremgangsmåte ved fremstilling av kinolin-3-carboxylsyrer. Process for the production of quinoline-3-carboxylic acids.
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av kinolin-3-carboxylsyrer og derivater derav som har verdifulle antibakterielle egenskaper og derfor kan anvendes som plantevernmidler eller som medisiner i veterinær- og human-terapien. The present invention relates to a method for the production of quinoline-3-carboxylic acids and derivatives thereof which have valuable antibacterial properties and can therefore be used as pesticides or as medicines in veterinary and human therapy.
Kinolin-3-carboxylsyrer og derivater derav representerer en meget viktig gruppe av forbindelsene med farmasøytisk anvendbarhet. ; l-alkyl-4-oxo-l,4_dihydro-kinolin-3-carboxylsyrer er verdifulle forbindelser som har antibakterielle egenskaper, og en av dem, nemlig 1-ethyl-6 , 7-methylendioxy -4-oxo-l ,4~dihydrokinolin-3-carboxylsyre (Journal of Medicinal Chemistry 11, l6o (1968) og britiske patenter nr. 1.076.828 og 3.287.458,).. har. allerede vært anvendt selv i terapien særlig for å helbrede urinveisinfeksjoner. Quinoline-3-carboxylic acids and derivatives thereof represent a very important group of compounds with pharmaceutical applicability. ; l-alkyl-4-oxo-l,4_dihydro-quinoline-3-carboxylic acids are valuable compounds that have antibacterial properties, and one of them, namely 1-ethyl-6 , 7-methylenedioxy -4-oxo-l ,4~dihydroquinoline -3-carboxylic acid (Journal of Medicinal Chemistry 11, l60 (1968) and British Patents Nos. 1,076,828 and 3,287,458,).. have. already been used even in therapy, especially to heal urinary tract infections.
En rekke fremgangsmåter er tidligere kjent for fremstilling av forbindelsene av denne gruppe. I henhold til den ene variant ringsluttes dialkyl-anilino^methylen-malonat, hhv. derivater derav, og derved fåes alkyl-4-hydroxy-kinolin-3-carboxylater. Derefter blir disse forbindelser N-alkylert, estergruppen underkastes hydrolyse, og de erholdte 1-alkyl-4-oxo-l,4_dihydro-kinolin-3-carboxylsyrer opparbeides til antibakterielle preparater. A number of methods are previously known for the preparation of the compounds of this group. According to one variant, dialkyl-anilino-methylene-malonate is ring-closed, resp. derivatives thereof, thereby obtaining alkyl-4-hydroxy-quinoline-3-carboxylates. These compounds are then N-alkylated, the ester group is subjected to hydrolysis, and the 1-alkyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acids obtained are processed into antibacterial preparations.
I henhold til en annen fremgangsmåte underkastes ethyl-2-(anilino-methylen)-acetoacetat en ringslutningsreaksjon, og derefter N-alkylering, og acetylgruppén på de dannede 3_acetyl-l-alkyl-4-oxo-1,4-dihydrokinolin-derivater omdannes til en carboxylgruppe ved en såkalt "haloform" reaksjon i nærvær av et halogen og en alkalihydroxydoppløsning (japanske patenter nr. 72.45-358 og 72.45.359). Reaksjonen fremgår av skjema B. According to another method, ethyl 2-(anilino-methylene)-acetoacetate is subjected to a ring closure reaction, and then N-alkylation, and the acetyl group of the 3-acetyl-1-alkyl-4-oxo-1,4-dihydroquinoline derivatives formed is converted to a carboxyl group by a so-called "haloform" reaction in the presence of a halogen and an alkali hydroxide solution (Japanese Patent Nos. 72,45-358 and 72,45,359). The reaction appears in form B.
Den siste variant har en betraktelig fordel fremfor den tidligere som består i muligheten for anvendelse av den billigere aceteddikester for fremstilling av ethyl-2-(anilino-methylen)-acetacetat istedenfor diethylmalonat, som er utgangsmaterialet ved fremstilling av diethyl-anilino-methylen-malonat. På den annen side er det en alvorlig ulempe ved denne reaksjon med henblikk på industriell utnyttelse at på grunn av den dårlige oppløselighet av 3-acetyl-1-ethyl-4-oxo-1,4-dihydro-kinolin, kan reaksjonen bare ut-føres i heterofase, og derfor er de tilsiktede kinolin-3-carboxyl-syrer vanskelige å reprodusere og kan fåes i lave utbytter. Det har nu vist seg at 3-acylgruppen i 3-acyl-4-oxo-l,4-dihydrp-kinoliner kan overføres til en carboxylgruppe i en to-trinns fremgangsmåte som er lett å utføre også i stor skala. I det første trinn blir en "A"-kvartær forbindelse fremstilt i nærvær av jod og en aromatisk heterocyclisk forbindelse inneholdende nitrogen. Denne reaksjon er illustrert i skjema C. The latter variant has a considerable advantage over the former which consists in the possibility of using the cheaper acetacetic acid ester for the production of ethyl-2-(anilino-methylene)-acetacetate instead of diethylmalonate, which is the starting material for the production of diethyl-anilino-methylene-malonate . On the other hand, there is a serious disadvantage of this reaction with a view to industrial utilization that, due to the poor solubility of 3-acetyl-1-ethyl-4-oxo-1,4-dihydro-quinoline, the reaction can only is conducted in heterophase, and therefore the intended quinoline-3-carboxylic acids are difficult to reproduce and can be obtained in low yields. It has now been shown that the 3-acyl group in 3-acyl-4-oxo-1,4-dihydrop-quinolines can be transferred to a carboxyl group in a two-step process which is easy to carry out also on a large scale. In the first step, an "A" quaternary compound is prepared in the presence of iodine and an aromatic heterocyclic compound containing nitrogen. This reaction is illustrated in Scheme C.
Ved foreliggende oppfinnelse må hydrolysen av de kvartære In the present invention, the hydrolysis of the quaternary
forbindelser beskyttes.connections are protected.
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av kinolin-3-carboxylsyrer med den generelle formel: The present invention relates to a process for the production of quinoline-3-carboxylic acids with the general formula:
hvor R er hydrogen, eventuelt substituert alkyl.., eventuelt substituert alkenyl eller eventuelt substituert aralkyl; R1 er hydrogen, halogen, eventuelt substituert alkyl, eventuelt substituert, aryl, eventuelt substituert aralkyl, eventuelt substituert cycloalkyl, eventuelt substituert araino, hydroxy, eventuelt substituert alkoxy, eventuelt substituert aralkyloxy, eventuelt substituert acyl, nitro, carboxyl, et derivat av carboxyl eller en eventuelt substituert 5~ til 7-leddet heterocyclisk ring med 1 - 3 nitrogenatomer som er forbundet med kinolinringen over et av nitrogenene, where R is hydrogen, optionally substituted alkyl.., optionally substituted alkenyl or optionally substituted aralkyl; R1 is hydrogen, halogen, optionally substituted alkyl, optionally substituted, aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted araino, hydroxy, optionally substituted alkoxy, optionally substituted aralkyloxy, optionally substituted acyl, nitro, carboxyl, a derivative of carboxyl or an optionally substituted 5~ to 7-membered heterocyclic ring with 1 - 3 nitrogen atoms which is connected to the quinoline ring over one of the nitrogens,
R 2 er hydrogen, halogen, eventuelt substituert alkyl, eventuelt substituert aralkyl, eventuelt substituert aryl, eventuelt substituert amino, nitro, hydroxyl, eventuelt substituert alkoxy, eventuelt substituert aralkyloxy, eller eventuelt substituert aryloxy; R 2 is hydrogen, halogen, optionally substituted alkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted amino, nitro, hydroxyl, optionally substituted alkoxy, optionally substituted aralkyloxy, or optionally substituted aryloxy;
R 3er hydrogen, halogen, eventuelt substituert alkyl, eventuelt substituert aralkyl, eventuelt substituert aryl, eventuelt substituert amino, hydroxyl, eventuelt substituert alkoxy, eller eventuelt substituert aryloxy; eller R 2 og RJ 3 kan sammen med 5,6-, 6,7- eller 7,8-sidene av kinolinringen danne en eventuelt substituert 5- til 7-leddet ring eventuelt inneholdende 1 eller 2 heteroatomer som kan være oxygen, R 3 is hydrogen, halogen, optionally substituted alkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted amino, hydroxyl, optionally substituted alkoxy, or optionally substituted aryloxy; or R 2 and RJ 3 can together with the 5,6-, 6,7- or 7,8-sides of the quinoline ring form an optionally substituted 5- to 7-membered ring optionally containing 1 or 2 heteroatoms which can be oxygen,
. svovel og/eller nitrogen; og .. sulfur and/or nitrogen; and .
nar n = 0, og R-<3>' er bundet til 8-stillingen av kinolinringen, kan R 3og R sammen danne en eventuelt substituert -(CH2)m-kjede, hvor m er 2, 3 eller 4; when n = 0, and R-<3>' is bound to the 8-position of the quinoline ring, R 3 and R together can form an optionally substituted -(CH 2 ) m chain, where m is 2, 3 or 4;
X er oxygen eller svovel; X is oxygen or sulfur;
4 4
R er hydroxyl eller mercapto,R is hydroxyl or mercapto,
som omfatter å underkaste en forbindelse med den generelle formel: which involves subjecting a compound of the general formula:
hvor R er hydrogen, eventuelt substituert alkyl, eventuelt substituert aryl, eventuelt substituert aralkyl eller eventuelt substituert cycloalkyl, R^ er hydrogen, eventuelt substituert alkyl, eventuelt substituert aryl eller eventuelt substituert aralkyl; where R is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted cycloalkyl, R 1 is hydrogen, optionally substituted alkyl, optionally substituted aryl or optionally substituted aralkyl;
Y er en aromatisk heterocyclisk ring inneholdende et tertiært nitrogen og bundet til ringen over nitrogenet eller en trialkyl-aminogruppe; og Y is an aromatic heterocyclic ring containing a tertiary nitrogen and attached to the ring above the nitrogen or a trialkylamino group; and
Z er et anion,Z is an anion,
hydrolyse.hydrolysis.
Hydrolysen utføres fortrinnsvis i et alkalisk medium. Som basisk hydrolyseringsmiddel kan et alkalihydroxyd, f .eks. kal.ium-hydroxy.d , nat riumhydroxyd; et jordalkalimeta 1lhydroxyd, f.eks. calciumhydroxyd; ammoniumhydroxyd, eller de tilsvarende carbonater eller hydrocarbonater og et alkalisk sulfid, f.eks. natriumsulfid; et alkalisk bisulfid, f.eks. nat riumbisulfid anvendes. The hydrolysis is preferably carried out in an alkaline medium. As a basic hydrolyzing agent, an alkali hydroxide, e.g. potassium-hydroxy.d , sodium hydroxide; an alkaline earth metal hydroxide, e.g. calcium hydroxide; ammonium hydroxide, or the corresponding carbonates or hydrocarbonates and an alkaline sulphide, e.g. sodium sulfide; an alkaline bisulphide, e.g. sodium bisulphide is used.
Hydrolyse kan også utføres i et nøytralt eller surt medium,Hydrolysis can also be carried out in a neutral or acidic medium,
i nærvær av et trialkylamin, fortrinnsvis triethylamin.in the presence of a trialkylamine, preferably triethylamine.
I nærvær av de ovenfor angitte hydrolyseringsmidler ut-føres hydrolysen fortrinnsvis i vann eller i nærvær av vann. og et med vann blandbart organisk oppløsningsmiddel, f.eks. ethanol, aceton, etc. In the presence of the above-mentioned hydrolyzing agents, the hydrolysis is preferably carried out in water or in the presence of water. and a water-miscible organic solvent, e.g. ethanol, acetone, etc.
Temperaturen ved hydrolysen kan variere fra 0° til 300°C, men fortrinnsvis er den mellom 10° og 200°C. The temperature during the hydrolysis can vary from 0° to 300°C, but preferably it is between 10° and 200°C.
Mineralsyren anvendt for surgjøring av reaksjonsblandingen er fortrinnsvis saltsyre, svovelsyre, eller som organisk syre kan fortrinnsvis maursyre eller eddiksyre anvendes. The mineral acid used for acidifying the reaction mixture is preferably hydrochloric acid, sulfuric acid, or as an organic acid preferably formic acid or acetic acid can be used.
Forbindelsen med den generelle formel I vil under hydrolysen eller efter at reaksjonsblandingen er surgjort, felles og kan fraskilles ved filtrering. The compound with the general formula I will, during the hydrolysis or after the reaction mixture has been acidified, come together and can be separated by filtration.
Uttrykket "eventuelt substituert alkyl" betegner fortrinnsvis en alkylgruppe, særlig methyl, ethyl, n-propyl, i-propyl; The expression "optionally substituted alkyl" preferably denotes an alkyl group, especially methyl, ethyl, n-propyl, i-propyl;
en aminoalky lgruppe , særlig aminomethyl, 1-piperidy.lmethyl, 2-amino.ethyl; en hydroxyalkylgruppe, fortrinnsvis hydroxymethy 1, 1- hydroxyethyl, 2-hydroxyethyl; en halogenalkylgruppe, fortrinnsvis klormethyl, 2-klorethyl; eller en cyanoalkylgruppe, fortrinnsvis cyanomethyl. an aminoalkyl group, especially aminomethyl, 1-piperidylmethyl, 2-aminoethyl; a hydroxyalkyl group, preferably hydroxymethyl 1, 1-hydroxyethyl, 2-hydroxyethyl; a haloalkyl group, preferably chloromethyl, 2-chloroethyl; or a cyanoalkyl group, preferably cyanomethyl.
Uttrykket "eventuelt substituert alkenyl" betegner fortrinnsvis en alkenylgruppe, fortrinnsvis allyl, vinyl; en amino-alkenylgruppe, fortrinnsvis 3-aminoallyl. The term "optionally substituted alkenyl" preferably denotes an alkenyl group, preferably allyl, vinyl; an amino-alkenyl group, preferably 3-aminoallyl.
Uttrykket "eventuelt substituert aryl" betegner fortrinnsvis en arylgruppe, fortrinnsvis fenyl, 2-nafthyl, 2-pyridyl, 3-pyridyl, 4-pyridyl; aryl med 1 eller 2 subst it u.enter, fortrinnsvis 3,4-dimethylfenyl, 3,4-dimethoxyfenyl. The term "optionally substituted aryl" preferably denotes an aryl group, preferably phenyl, 2-naphthyl, 2-pyridyl, 3-pyridyl, 4-pyridyl; aryl with 1 or 2 substituents, preferably 3,4-dimethylphenyl, 3,4-dimethoxyphenyl.
Uttrykket "eventuelt substituert aralkyl" betegner fortrinnsvis en aralkylgruppe, fortrinnsvis benzyl, 2-fenylethyl; en aralkylgruppe med 1 eller 2 substituenter, f.eks. (3,4-dimethylfenyl)-methyl, 2-(3,4-dimethoxy-fenyl)-ethy1. The term "optionally substituted aralkyl" preferably denotes an aralkyl group, preferably benzyl, 2-phenylethyl; an aralkyl group with 1 or 2 substituents, e.g. (3,4-dimethylphenyl)-methyl, 2-(3,4-dimethoxy-phenyl)-ethyl.
Uttrykket "eventuelt substituert cycloalkyl" betegner fortrinnsvis en c.ycloalkylgruppe, fortrinnsvis cyclohexyl, cyclo-pentyl, cycloheptyl, cyclohexyl-methyl; en cycloalkylgruppe med 1 eller 2 substituenter., fortrinnsvis 2-hydroxy-cyclohexyl, 3-hydroxy-cyclohexyl, 4-hydroxy-cyclohexyl. The term "optionally substituted cycloalkyl" preferably denotes a cycloalkyl group, preferably cyclohexyl, cyclopentyl, cycloheptyl, cyclohexylmethyl; a cycloalkyl group with 1 or 2 substituents, preferably 2-hydroxy-cyclohexyl, 3-hydroxy-cyclohexyl, 4-hydroxy-cyclohexyl.
Uttrykket "halogen" er fortrinnsvis klor eller brom. The term "halogen" is preferably chlorine or bromine.
Uttrykket "eventuelt substituert alkoxy" betegner fortrinnsvis en alkoxygruppe, og særlig •■met hoxy , et hoxy, iso-butoxy, n-decyl-oxy, n-octyloxy, n-heptyloxy; en amino-.alkoxy gruppe, fortrinnsvis 2- amino-ethoxy, 2-(1-piperidyl)-ethoxy. The term "optionally substituted alkoxy" preferably denotes an alkoxy group, and in particular met hoxy, et hoxy, iso-butoxy, n-decyl-oxy, n-octyloxy, n-heptyloxy; an amino- . . . alkoxy group, preferably 2-amino-ethoxy, 2-(1-piperidyl)-ethoxy.
Uttrykket "eventuelt substituert aralkoxy" betegner fortrinnsvis en aralkoxygruppe, mere spesielt en benzyloxygruppe; The term "optionally substituted aralkyl" preferably denotes an aralkyl group, more particularly a benzyloxy group;
en aralkoxygruppe med 1 eller 2 substituenter, fortrinnsvis 4-methoxy-benzyl, 3,4-dimethoxy-benzyl, 3,4-methylendioxy-benzyl. an aralkyl group with 1 or 2 substituents, preferably 4-methoxy-benzyl, 3,4-dimethoxy-benzyl, 3,4-methylenedioxy-benzyl.
Uttrykket "eventuelt substituert acyl" betegner fortrinnsvis en acylgruppe, særlig formyl, acetyl, propionyl, benzoyl; The term "optionally substituted acyl" preferably denotes an acyl group, especially formyl, acetyl, propionyl, benzoyl;
en acylgruppe med 1 eller 2 substituenter, fortrinnsvis hydroxy-acetyl, kloracetyl, aminoacetyl, (1-piperidyl)-acetyl, 3,4-dimethoxybenzoyl. "Carboxylsyrederivatgruppen" er fortrinnsvis en alkoxy-carbonylgruppe, fortrinnsvis methoxy-carbonyl, ethoxy-carbonyl, benzyloxy-carbonyl; en carboxylsyre-amidgruppe, spesielt carboxamid, N-ethyl-carboxamid, piperidyl-carbonyl, aziridinyl-carbonyl. an acyl group with 1 or 2 substituents, preferably hydroxy-acetyl, chloroacetyl, aminoacetyl, (1-piperidyl)-acetyl, 3,4-dimethoxybenzoyl. The "carboxylic acid derivative group" is preferably an alkoxy-carbonyl group, preferably methoxy-carbonyl, ethoxy-carbonyl, benzyloxy-carbonyl; a carboxylic acid amide group, especially carboxamide, N-ethylcarboxamide, piperidylcarbonyl, aziridinylcarbonyl.
Uttrykket "eventuelt substituert 5- til 7-leddet heterocyclisk gruppe med 1-3 nitrogenatomer" betegner fortrinnsvis en heterocyclisk gruppe, mere spesielt pyrrolidinyl, piperazinyl, aziridinyl, pyrazolidinyl, imidazolidinyl, indolinyl , pyrrolinyl,-hexahydro-1,3,5-triazinyl, hexahydro-lH-azepinyl; en heterocyclisk gruppe med 1 eller 2 substituenter, fortrinnsvis 3-hydroxy-pyrrolidinyl, 3-acetoxy-pyrrolidinyl, 3-formyl-pyrrolidinyl, 3-benzyloxy-pyrrolidinyl, 4-methyl-piperazinyl, 4~ethyl-piperazinyl, 4-formyl-piperazinyl, 4-acetyl-piperazinyl, 4-benzyl-piperazinyl. The term "optionally substituted 5- to 7-membered heterocyclic group with 1-3 nitrogen atoms" preferably denotes a heterocyclic group, more particularly pyrrolidinyl, piperazinyl, aziridinyl, pyrazolidinyl, imidazolidinyl, indolinyl, pyrrolinyl, -hexahydro-1,3,5-triazinyl , hexahydro-1H-azepinyl; a heterocyclic group with 1 or 2 substituents, preferably 3-hydroxy-pyrrolidinyl, 3-acetoxy-pyrrolidinyl, 3-formyl-pyrrolidinyl, 3-benzyloxy-pyrrolidinyl, 4-methyl-piperazinyl, 4-ethyl-piperazinyl, 4-formyl- piperazinyl, 4-acetyl-piperazinyl, 4-benzyl-piperazinyl.
Gruppene R 2 og R 3 kan sammen med en 5,6-, 6,7- eller 7,8-side av kinolinringen danne en .benzen-, pyridin-, cyclohexen-, cyclopenten-, cyclphepten-, thiazol-, oxazol-, i.sothiazol-, isoxa-zol-, thiazolin-, isothiazolin-, oxazolin-, isoxazolin-, 1,3-dioxol-, 2 ,3-dihydro-l ,4-dioxen- eller 2 ,/f-H-l, 3-dioxenring , som eventuelt kan være substituert med 1 eller flere substituenter. The groups R 2 and R 3 can together with a 5,6-, 6,7- or 7,8-side of the quinoline ring form a .benzene-, pyridine-, cyclohexene-, cyclopentene-, cycloheptene-, thiazole-, oxazol- , i.sothiazole-, isoxa-zole-, thiazoline-, isothiazoline-, oxazoline-, isoxazoline-, 1,3-dioxole-, 2,3-dihydro-1,4-dioxene- or 2,/f-H-1, 3- dioxene ring, which may optionally be substituted with 1 or more substituents.
Som utgangsmaterialer kan de tilsvarende pyridinium-, kinolinium-, isokinolinium-, alkylsubstituert pyridinium- (fortrinns-, vis picolinium), kinaldinium- eller lepidinium-jodid, -bromid, As starting materials, the corresponding pyridinium, quinolinium, isoquinolinium, alkyl-substituted pyridinium (preferably, vis picolinium), quinaldinium or lepidinium iodide, bromide,
-perklorat, -sulfat, -fosfat eller -nitrat-kvartære salter av forbindelsene med den generelle formel II anvendes. Passende utgangsmaterialer er videre trialkylammoniumjodid, -bromid, -klorid, -perklorat, -sulfat, -fosfat eller -nit rat-kvartære salter, av forbindelsene med den generelle formel II. -perchlorate, -sulphate, -phosphate or -nitrate quaternary salts of the compounds of the general formula II are used. Suitable starting materials are further trialkylammonium iodide, -bromide, -chloride, -perchlorate, -sulfate, -phosphate or -nitrate quaternary salts, of the compounds of the general formula II.
Forbindelser med den generelle formel II er nye forbindelser, og kan fremstilles på følgende måte: Compounds with the general formula II are new compounds, and can be prepared in the following way:
a) En forbindelse med den generelle formel:a) A compound with the general formula:
hvor n, R, R<1>, R<2>, R<3>, R5, R6 og X er som ovenfor angitt, omsettes med en Y-aromatisk heterocyclisk forbindelse, inneholdende et tertiært nitrogenatom i nærvær av jod, eller. where n, R, R<1>, R<2>, R<3>, R5, R6 and X are as indicated above, is reacted with a Y-aromatic heterocyclic compound, containing a tertiary nitrogen atom in the presence of iodine, or.
b) en forbindelse med den generelle formel:b) a compound with the general formula:
hvor n, R, R , R , R ,. R , R og X er som ovenfor angitt, og Z where n, R, R , R , R ,. R , R and X are as above, and Z
betegner et halogénatom, i nærvær av et oppløsningsmiddel eller uten oppløsningsmiddel omsettes med en Y-aromatisk heterocyclisk forbindelse, med et tertiært nitrogenatom, eller med. et trialkyl-amino. denotes a halogen atom, in the presence of a solvent or without a solvent is reacted with a Y-aromatic heterocyclic compound, with a tertiary nitrogen atom, or with. a trialkyl-amino.
I kvaterneringsreaksjonen kan de konvensjonelt anvendte oppløsningsmidler, fortrinnsvis benzen, aceton, acetohitril, nitro-methan, dimethylformamid, etc., anvendes. In the quaternization reaction, the conventionally used solvents, preferably benzene, acetone, acetohydril, nitromethane, dimethylformamide, etc., can be used.
Videre fordeler ved foreliggende oppfinnelse vil fremgå av de følgende eksempler. Further advantages of the present invention will be apparent from the following examples.
Eksempel . 1Example . 1
2,32 g (5 mmol) l-ethyl-6,7-methylendioxy-4-oxo-l,4-dihydro -kinolin-3 -ca rbonyl -methyl -pyridinium jodid sprinkles i en oppløsning av 1 g natriumhydroxyd i 25 ml vann, og reaksjonsblandingen kokes i 1 time. Blandingen avkjøles, og pH innstilles på 1-2. De utfelte krystaller f rafiltreres, dekkes med vann, og tørres. 1,1 g (90%) 1-ethyl-6,7-methylendioxy-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre fåes, som smelter ved 3l4°C(spaltning) efter omkrystallisåsjon fra dimethylformamid. 2.32 g (5 mmol) of l-ethyl-6,7-methylenedioxy-4-oxo-l,4-dihydro-quinoline-3-ca rbonyl-methyl-pyridinium iodide is sprinkled into a solution of 1 g of sodium hydroxide in 25 ml water, and the reaction mixture is boiled for 1 hour. The mixture is cooled, and the pH is adjusted to 1-2. The precipitated crystals are filtered off, covered with water and dried. 1.1 g (90%) of 1-ethyl-6,7-methylenedioxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 314°C (decomposition) after recrystallization from dimethylformamide.
Elementæranalyse:Elemental analysis:
Eksempel 2 Example 2
2,32 g (5 mmol) 1-ethy1-6,7-methylendioxy-4~oxo-1,4~dihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i 25 ml vann i nærvær av 28 ml triethylamin i 16 timer. Derefter avkjøles oppløsningen til værelsetearperatur, og hensettes i flere dager. 2.32 g (5 mmol) of 1-ethy1-6,7-methylenedioxy-4~oxo-1,4~dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide are boiled in 25 ml of water in the presence of 28 ml of triethylamine for 16 hours. The solution is then cooled to room temperature and set aside for several days.
De utfelte krystaller frafiltreres, dekkes med vann, og tørres. 1,1 g (85%) 1-ethyl-6,7-methylendioxy-4-oxo-1,4-dihydro-kinolin-3-carboxylsyre fåes, som smelter ved 313 - 3l4°C (spaltning) efter omkrystallisåsjon fra dimethylformamid. Produktet fra foreliggende eksempel gir ikke noen smeltepunktsnedsettelse ved blanding med produktet fra eksempel 1. The precipitated crystals are filtered off, covered with water and dried. 1.1 g (85%) of 1-ethyl-6,7-methylenedioxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 313 - 314°C (decomposition) after recrystallization from dimethylformamide . The product from the present example does not cause any melting point reduction when mixed with the product from example 1.
Eksempel 3Example 3
2,189(5 mmol) 6 , 7-methylendioxy-4,oxo-l ,4.-dihydro-kinolin-3-carbonyl-methyl-piperidiniumjodid kokes i 25 ml vann i nærvær av 1 g natriumhydroxyd i 1 time. Reaksjonsblandingen avkjøles til. værelsétemperatur, og pH innstilles på 1 - 2. De utfelte krystaller frafiltreres. Man får 1,0 g (86%) 6,7-methylendioxy-4-oxo-1,4-dihydro-kinolin-3-carboxylsyre, som smelter over 310°C. 2.189 (5 mmol) of 6,7-methylenedioxy-4,oxo-1,4.-dihydro-quinoline-3-carbonyl-methyl-piperidinium iodide is boiled in 25 ml of water in the presence of 1 g of sodium hydroxide for 1 hour. The reaction mixture is cooled to room temperature, and the pH is set to 1 - 2. The precipitated crystals are filtered off. 1.0 g (86%) of 6,7-methylenedioxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts above 310°C.
Elementæranalyse:Elemental analysis:
Eksempel 4 Example 4
2,17 g (5 mmol) 5,6,8-trimethyl-4-oxo-l,4-dihydro-kinolin-3-carbony.l-methyl-pyridinium jodid kokes i 25 ml vann i nærvær av 1 g natriumhydroxyd i 1 time.. Reaksjonsblandingen avkjøles til værelsetemperatur, og pH innstilles på 1 - 2. De utfelte krystaller frafiltreres , dekkes med vann og tørres. 1,10 g.(95%) 5,6,8-methyl-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre fåes, som spalter ved 273 - 275°C. 2.17 g (5 mmol) of 5,6,8-trimethyl-4-oxo-1,4-dihydro-quinoline-3-carbonyl.1-methyl-pyridinium iodide are boiled in 25 ml of water in the presence of 1 g of sodium hydroxide in 1 hour.. The reaction mixture is cooled to room temperature, and the pH is adjusted to 1 - 2. The precipitated crystals are filtered off, covered with water and dried. 1.10 g. (95%) of 5,6,8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which decomposes at 273 - 275°C.
Elementæranalyse:Elemental analysis:
Eksempel 5 Example 5
2,31 g (5 mmol) l-ethyl-6-klor-4-oxo-l,4-dihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i 25 ml vann i nærvær av 1 g natriumhydroxyd il time: Oppløsningen avkjøles til værelsetemperatur, og pH innstilles på 1 - 2. De utfelte krystaller f ra - filtreres, dekkes med vann og tørres. Man får 1,2 g (96%) 1-ethyl-6-klor-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 235 - 237°C. 2.31 g (5 mmol) of 1-ethyl-6-chloro-4-oxo-1,4-dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide is boiled in 25 ml of water in the presence of 1 g of sodium hydroxide for 1 hour: The solution cooled to room temperature, and the pH is adjusted to 1 - 2. The precipitated crystals are filtered, covered with water and dried. 1.2 g (96%) of 1-ethyl-6-chloro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 235 - 237°C.
Elementæranalyse:Elemental analysis:
Eksempel 6 Example 6
2,25 g (5 mmol) 1-ethyl-6-methoxy-4-oxo-l,4-dihydro-kinolin-3-carbonyl-raethyl-pyridiniumjodid kokes i 25 ml vann i nærvær av lg natriumhydroxyd i 1 time. Oppløsningen avkjøles til værelsetemperatur, og pH innstilles på 1 - 2 med en vandig oppløsning av hydrogenklorid. De utfelte krystaller frafiltreres, vaskes med vann og tørres. Man får 1,07 g (87,0%) 1-ethyl-6-methoxy-4-oxo-1,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 222 - 223°C. 2.25 g (5 mmol) of 1-ethyl-6-methoxy-4-oxo-1,4-dihydro-quinoline-3-carbonyl-raethyl-pyridinium iodide is boiled in 25 ml of water in the presence of 1 g of sodium hydroxide for 1 hour. The solution is cooled to room temperature, and the pH is adjusted to 1 - 2 with an aqueous solution of hydrogen chloride. The precipitated crystals are filtered off, washed with water and dried. 1.07 g (87.0%) of 1-ethyl-6-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 222 - 223°C.
Elementæranalyse:Elemental analysis:
Eksempel 7 Example 7
2,16 g (5 mmol) 1-et.hyl-7-methyl-4-oxo-l, 4-d'ihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i .25 ml vann i nærvær av 1 g natriumcarbonat i 2 timer. Derefter innstilles oppløs- 2.16 g (5 mmol) of 1-ethyl-7-methyl-4-oxo-1,4-dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide are boiled in .25 ml of water in the presence of 1 g sodium carbonate for 2 hours. Then set the resolution
ningens pH på 1 - 2 med eddiksyre. De utfelte krystaller frafiltreres, vaskes med vann og tørres. Man får 0,95 Q (80%) 1-ethyl-7-methyl-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 285 .- 2'86°C. ning's pH of 1 - 2 with acetic acid. The precipitated crystals are filtered off, washed with water and dried. 0.95 Q (80%) of 1-ethyl-7-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 285.-2.86°C.
Elementæranalyse:Elemental analysis:
Eksempel 8 Example 8
2,10 g (5 mmol) l-ethyl-4-oxo-l,4~dihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i 25 ml vann og 5 ml 34 vekt%-ig natriumhydroxyd i 1 time.Reaksjonsblandingen av-kjøles til værelsetemperatur, og pH innstilles på 1 - 2. De utfelte krystaller frafiltreres, vaskes med vann og tørres. Man får 0,90 g (83%) l-ethyl-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 251 - 252°C. 2.10 g (5 mmol) of 1-ethyl-4-oxo-1,4-dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide is boiled in 25 ml of water and 5 ml of 34% by weight sodium hydroxide for 1 hour. The reaction mixture cooled to room temperature, and the pH is adjusted to 1 - 2. The precipitated crystals are filtered off, washed with water and dried. 0.90 g (83%) of 1-ethyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 251 - 252°C.
Elementæranalyse:Elemental analysis:
Eksempel 9 Example 9
2,039(5 mmol) 8-met hy1-4-oxo-1,4-dihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i 25.ml vann, i nærvær av lg natriumhydroxyd i 1 time. Oppløsningen avkjøles til værelsetemperatur, og pH innstilles på 1 - 2. De utfelte krystaller frafiltreres, vaskes med vann og tørres. Man får 0,90 g (89%) 8~methyl-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som spaltes ved 276 - 277°C. 2.039 (5 mmol) of 8-methyl-4-oxo-1,4-dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide is boiled in 25 ml of water, in the presence of 1 g of sodium hydroxide for 1 hour. The solution is cooled to room temperature, and the pH is adjusted to 1 - 2. The precipitated crystals are filtered off, washed with water and dried. 0.90 g (89%) of 8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which decomposes at 276 - 277°C.
Elementæranalyse: Elemental analysis:
Eksempel 10 Example 10
2,15 g (5 mmol) 6-nitro-4-oxo-l ,4-dihydro-kinolin-3-carbonyl-.. methyl-pyridiniumjodid kokes i 25 ml vann i nærvær av 1 g natriumhydroxyd i 1 time. Oppløsningen avkjøles til værelsetemperatur,. og PH innstilles på .1 - 2. De utfelte krystaller f raf ilt reres , vaskes med vann og tørres. Man får 1,15 g (98%) 6-nitro-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 283 - 284°C. 2.15 g (5 mmol) of 6-nitro-4-oxo-1,4-dihydro-quinoline-3-carbonyl-..methyl-pyridinium iodide are boiled in 25 ml of water in the presence of 1 g of sodium hydroxide for 1 hour. The solution is cooled to room temperature. and the PH is set to .1 - 2. The precipitated crystals are filtered off, washed with water and dried. 1.15 g (98%) of 6-nitro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 283 - 284°C.
Elementæranalyse: Elemental analysis:
Eksempel 11 Example 11
1,02 g (2,5 mmol) 7-hydroxy-4-oxo-1,4-dihydro-kinolin-3-carbonyl-methyl-pyridiniumjodid kokes i 15 ml vann i nærvær av 1.02 g (2.5 mmol) of 7-hydroxy-4-oxo-1,4-dihydro-quinoline-3-carbonyl-methyl-pyridinium iodide is boiled in 15 ml of water in the presence of
0,5 g natriumhydroxyd. Oppløsningen avkjøles til værelsetempera-. tur, og pH innstilles på 1 - 2. De utfelte krystaller frafiltreres, vaskes med vann og tørres. Man får 0,50 g (98%) 7-hydroxy-4-oxo-l,4-dihydro-kinolin-3-carboxylsyre, som smelter ved 242 -244°c. 0.5 g sodium hydroxide. The solution is cooled to room temperature. turn, and the pH is adjusted to 1 - 2. The precipitated crystals are filtered off, washed with water and dried. 0.50 g (98%) of 7-hydroxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid is obtained, which melts at 242-244°C.
Elementæranalyse:Elemental analysis:
Claims (7)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU75CI00001585A HU170951B (en) | 1975-06-06 | 1975-06-06 | New process for preparing 3-quinolinecarboxylic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
NO761926L true NO761926L (en) | 1976-12-07 |
Family
ID=10994570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO761926A NO761926L (en) | 1975-06-06 | 1976-06-04 |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS51146476A (en) |
DK (1) | DK247976A (en) |
ES (1) | ES448619A1 (en) |
FI (1) | FI761583A (en) |
GB (1) | GB1502405A (en) |
HU (1) | HU170951B (en) |
NO (1) | NO761926L (en) |
SE (1) | SE7606308L (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5540616A (en) * | 1978-09-14 | 1980-03-22 | Otsuka Pharmaceut Co Ltd | Preparation of benzo-hetero-compound |
JPS58105965A (en) * | 1981-12-15 | 1983-06-24 | Nippon Shinyaku Co Ltd | Substituted quinolinecarboxylic acid derivative |
JPS61143363A (en) * | 1984-12-17 | 1986-07-01 | Kyorin Pharmaceut Co Ltd | Production of quinolonecarboxylic acid derivative |
JPS61143364A (en) * | 1984-12-17 | 1986-07-01 | Kyorin Pharmaceut Co Ltd | Production of quinolonecarboxylic acid derivative |
DE3705621C2 (en) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclic substituted quinolonecarboxylic acid derivatives |
JPS6483068A (en) * | 1987-09-25 | 1989-03-28 | Otsuka Pharma Co Ltd | Production of benzo-heterocyclic compound |
DE69528160T2 (en) * | 1994-03-01 | 2003-02-06 | Chemipro Kasei Kaisha, Ltd. | METHOD FOR PRODUCING 5,7 DICHLOR-4-HYDROXYCHINOLINE |
-
1975
- 1975-06-06 HU HU75CI00001585A patent/HU170951B/en unknown
-
1976
- 1976-06-03 SE SE7606308A patent/SE7606308L/en not_active Application Discontinuation
- 1976-06-04 FI FI761583A patent/FI761583A/fi not_active Application Discontinuation
- 1976-06-04 GB GB23285/76A patent/GB1502405A/en not_active Expired
- 1976-06-04 NO NO761926A patent/NO761926L/no unknown
- 1976-06-04 DK DK247976A patent/DK247976A/en not_active Application Discontinuation
- 1976-06-05 ES ES448619A patent/ES448619A1/en not_active Expired
- 1976-06-07 JP JP51065718A patent/JPS51146476A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
HU170951B (en) | 1977-10-28 |
JPS51146476A (en) | 1976-12-16 |
DK247976A (en) | 1976-12-07 |
ES448619A1 (en) | 1977-07-01 |
FI761583A (en) | 1976-12-07 |
SE7606308L (en) | 1976-12-07 |
GB1502405A (en) | 1978-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE440353B (en) | QUINOLINE CARBOXYLIC ACID DERIVATIVES AND SETS FOR PREPARING THEREOF | |
KR960002273B1 (en) | 6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinoline | |
CA1216849A (en) | Quinolone acids, processes for their preparation and antibacterial agents containing these compounds | |
KR870001944B1 (en) | Preparation process of quinoline carboxylic acid derivatives | |
NO761926L (en) | ||
KR970005911B1 (en) | Process for preparing quinoline carboxylic acid derivatives | |
NO179517B (en) | Process for the preparation of 8-chloroquinolone derivatives | |
EP0090360B1 (en) | New quinoline and related compounds useful as anti-allergy agents | |
KR100519158B1 (en) | A process for preparation of quinolone carboxylate derivatives | |
DE3138121A1 (en) | CHINOLONES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THERAPEUTIC PREPARATIONS | |
US4522947A (en) | Certain 1,3-oxazolo[4,5H]quinolines useful as anti-allergy agents | |
DE69230730T2 (en) | METHOD FOR PRODUCING BENZO [b] NAPHTHYRIDINES | |
US3835141A (en) | Quinalythiohydroximic acids and their derivatives | |
US3433802A (en) | 3-(n-lower-alkylanilino)pyrrolidines | |
AT397385B (en) | METHOD FOR PRODUCING CHINOLINE CARBONIC ACID DERIVATIVES | |
KR900001219B1 (en) | Quinoline derivatives, and process for preparation thereof | |
CS261250B2 (en) | Method of 1-methylaminoquinolinecarboxyl acid's and its derivatives production | |
EP0285655B1 (en) | Process for the preparation of quinoline-carboxylic acid derivatives | |
EP0195135B1 (en) | A process for the preparation of quinoline carboxylic acid derivatives | |
US4656281A (en) | Imidazo quinoline compounds useful as anti-allergy agents | |
KR870001624B1 (en) | Process for preparing quinoline derivatives | |
US4921961A (en) | 2-Carbamoyl-3-quinolinecarboxylic acids and salts as intermediates for the preparation of herbicidal 2-(5-isoproyl-5-methyl-4-oxo-2-imidazolin-2-yl)-3-quinolinecarboxylic acids | |
RU2049783C1 (en) | Method of synthesis of quinoline carboxylic acid derivatives or their pharmaceutically acceptable salts | |
JPH0720940B2 (en) | Process for producing quinoline derivative | |
HUT67395A (en) | Method for the n-cyclopropylation of primary and secondary aromatic amines |